Bevacizumab/PD-1 inhibitor plus chemotherapy as first-line treatment of advanced non-squamous non-small-cell lung cancer
Aim: To compare the effectiveness of PD-1 inhibitor or bevacizumab plus chemotherapy in advanced nonsquamous non-small cell lung cancer (nsNSCLC). Methods: We retrospectively collected data for patients with advanced nsNSCLC who underwent first-line treatment with PD-1 inhibitor or bevacizumab plus...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Book |
| Published: |
Becaris Publishing Limited,
2023-04-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|